AAAAAA

   
Results: 1-11 |
Results: 11
Efficacy of ultra-pure dialysate in the therapy and prevention of haemodialysis-associated amyloidosis
Authors: Lonnemann, G Koch, KM
Citation: G. Lonnemann et Km. Koch, Efficacy of ultra-pure dialysate in the therapy and prevention of haemodialysis-associated amyloidosis, NEPH DIAL T, 16, 2001, pp. 17-22
Are standards for dialysate purity in hemodialysis insufficiently strict?
Authors: Lonnemann, G
Citation: G. Lonnemann, Are standards for dialysate purity in hemodialysis insufficiently strict?, SEMIN DIAL, 14(5), 2001, pp. 331-333
Effects of dialyzer membrane on interleukin-1 beta (IL-1 beta) and IL-1 beta-converting enzyme in mononuclear cells
Authors: Linnenweber, S Lonnemann, G
Citation: S. Linnenweber et G. Lonnemann, Effects of dialyzer membrane on interleukin-1 beta (IL-1 beta) and IL-1 beta-converting enzyme in mononuclear cells, KIDNEY INT, 59, 2001, pp. S282-S285
Cytokines and long-term renal replacement therapies
Authors: Kierdorf, HP Lonnemann, G
Citation: Hp. Kierdorf et G. Lonnemann, Cytokines and long-term renal replacement therapies, INTERNIST, 42(1), 2001, pp. 86-91
Pyrogen retention by the Asahi APS-650 polysulfone dialyzer during in vitro dialysis with whole human donor blood
Authors: Linnenweber, S Lonnemann, G
Citation: S. Linnenweber et G. Lonnemann, Pyrogen retention by the Asahi APS-650 polysulfone dialyzer during in vitro dialysis with whole human donor blood, ASAIO J, 46(4), 2000, pp. 444-447
Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system
Authors: Lonnemann, G Floege, J Kliem, V Brunkhorst, R Koch, KM
Citation: G. Lonnemann et al., Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system, NEPH DIAL T, 15(8), 2000, pp. 1189-1193
Should ultra-pure dialysate be mandatory?
Authors: Lonnemann, G
Citation: G. Lonnemann, Should ultra-pure dialysate be mandatory?, NEPH DIAL T, 15, 2000, pp. 55-59
Chronic inflammation in hemodialysis: The role of contaminated dialysate
Authors: Lonnemann, G
Citation: G. Lonnemann, Chronic inflammation in hemodialysis: The role of contaminated dialysate, BLOOD PURIF, 18(3), 2000, pp. 214-223
Clinical relevance of hemodialysis-associated induction of cytokines
Authors: Lonnemann, G
Citation: G. Lonnemann, Clinical relevance of hemodialysis-associated induction of cytokines, NIEREN HOCH, 28(2), 1999, pp. 49-55
Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill
Authors: Tetta, C Bellomo, R Brendolan, A Piccinni, P Digito, A Dan, M Irone, M Lonnemann, G Moscato, D Buades, J La Greca, G Ronco, C
Citation: C. Tetta et al., Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill, KIDNEY INT, 56, 1999, pp. S15-S19
Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure
Authors: Lonnemann, G Bechstein, M Linnenweber, S Burg, M Koch, KM
Citation: G. Lonnemann et al., Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure, KIDNEY INT, 56, 1999, pp. S84-S87
Risultati: 1-11 |